1 active not recruiting, 1 unknown. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Active not recruiting 1, Unknown 1 |
Follow PCV20: new trials by email Literature Review of PCV20 trials Research Report on PCV20
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Immunogenicity and Clinical Efficacy of 20-valent Pneumococcal Conjugate Vaccine (PCV20) in Lymphoma Survivors After Treatment With Anti-CD20 Therapy PCV20 - Lymphoma | Phase 4 | Active not recruiting | M.D. Anderson Cancer Center | 30 | 2023-10-06 | 2026-09-15 |
| Concomitant Administration of the Novavax Vaccine and a 20-valent Pneumococcal Conjugate Vaccine in Adults Aged ≥60 Years NVX, PCV20, Placebo - COVID-19, Pneumococcal Infections | Phase 4 | Unknown | Medical University of Vienna | 256 | 2023-03-01 | 2023-03-15 |
COVID-19 (1) · Lymphoma (1) · Pneumococcal Infections (1)
M.D. Anderson Cancer Center (1) · Medical University of Vienna (1)
United States (1)